Clinical trial
Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset
NCT02806258 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- April 26, 2016
- Completion date
- May 16, 2025
- Enrollment
- 362 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
intermediate and high-risk luminal and triple negative breast cancer, radiation therapy, breast cancer, sequential partial breast irradiation